alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

   Confidential Materials omitted and filed separately with the Securities and
                Exchange Commission. Asterisks denote omissions.

                                                                    Exhibit 10.1

                      FIRST AMENDMENT TO LICENSE AGREEMENT
                                 BY AND BETWEEN

                           BOSTON LIFE SCIENCES, INC.

                                       AND

                            BIOAXONE THERAPEUTIC INC.

This first Amendment to the License Agreement (the "License") between Boston
Life Sciences, Inc. ("BLSI") and BioAxone Therapeutic, Inc. ("BA") dated as of
December 28, 2006 is made effective as of March 23, 2007.

For good and valuable consideration BLSI and BA hereby agree that the Licensed
Patent Rights described in Section 1.34 of the License and the therein
referenced Exhibit B is amended to include the following addition to Table 1 of
said Exhibit B:

<TABLE>
<CAPTION>
Country   Application Number   Filing Date   Patent Number   Status   Title
-------   ------------------   -----------   -------------   ------   -----
<S>       <C>                  <C>           <C>             <C>      <C>
[**]      [**]                 [**]          [**]            [**]     [**]
</TABLE>


The parties further agree that said Table 1 of said Exhibit B is updated as
follows for purposes of clarification:

<TABLE>
<CAPTION>
Country   Application Number   Filing Date   Patent Number   Status   Title
-------   ------------------   -----------   -------------   ------   -----
<S>       <C>                  <C>           <C>             <C>      <C>
[**]      [**]                 [**]          [**]            [**]     [**]
REPLACE ABOVE WITH:
[**]      [**]                 [**]          [**]            [**]     [**]
</TABLE>

IN WITNESS WHEREOF, the parties have executed this First Amendment as of the
date first set forth above.

BOSTON LIFE SCIENCES, INC.


By /s/ Kenneth L. Rice
   ----------------------------------
Title EVP & CFO


BIOAXONE THERAPEUTIC INC.


By /s/ Frank Bobe
   ----------------------------------
Title President & CEO
DISMISS and Opinion Filed February 23, 2023 

# S

In The 

### Court of Appeals Fifth District of Texas at Dallas

No. 05-22-01211-CV PACK PROPERTIES XIV, LLC AND T&T REALTY CORP ., Appellants

V.
REMINGTON PROSPER, LLC, Appellee
On Appeal from the 471st Judicial District Court Collin County, Texas Trial Court Cause No. 471-04301-2021

MEMORANDUM OPINION Before Chief Justice Burn s, Justice Pedersen, III, and Justice Goldstein Opinion by Chief Justice Burns We questioned our jurisdiction over this appeal from three summary judgment
orders as the orders did not, individually or in combinati on, appear to dispose of all
claims and parties. See Lehmann v. Har-Con Corp. , 39 S.W.3d 191, 195 (Tex. 2001)
(generally, appeal may only be taken from fina l judgment that disposes of all parties
and claims). At our request, the par ties filed jurisdictional letter briefs.–2– After appellants’ le tter brief was filed, 1 the trial judge signed an order that
clarified that parties and claims remain pending. Accordingly, because claims
remain pending, we lack jurisd iction and dismiss the appeal. See T EX

. R. A PP

. P.
42.3(a); Lehmann , 39 S.W.3d at 195.

221211F.P05

1 In their letter brief, appellants argued that, based on a “306a letter” that the district clerk had sent them following the signing of the summary judgment orders and that informed them that “an appealable order or other final order disposing of the case” had been signed, it appeared the trial court intended the summary judgment orders to be final. See T EX

. R. C IV

. P. 306a(3) (requiring court clerk to immediately give parties notice when final judgment or other appealable order is signed); see also Lehmann , 39 S.W.3d at 205 (when no conventional trial on the merits has occurred, order or judgment is final and appealable if it clearly shows trial court intended to completely dispose of entire case) . Appellants requested that, in the event we were uncertain, we abate the appeal for the trial court to clarify its intent. See id. at 206. Appellee informed the Court in its letter brief of the clarifying order. /Robert D. Burns, III / ROBERT D. BURNS, III CHIEF JUSTICE–3– 

# S

Court of Appeals Fifth District of Texas at Dallas
JUDGMENT

PACK PROPERTIES XIV, LLC AND T&T REALTY CORP., Appellants

No. 05-22-01211-CV V.

REMINGTON PROSPER, LLC, Appellee On Appeal from the 471st Judicial District Court, Collin County, Texas Trial Court Cause No. 471-04301- 2021. Opinion delivered by Chief Justice Burns, Justices Pedersen, III and Goldstein participating.

In accordance with this Court’ s opinion of this date, we DISMISS the appeal.

We ORDER that appellee Remington Prosper, LLC recover its costs, if any, of this appeal from appellants Pack Pr operties XIV, LLC and T&T Realty Corp.

Judgment entered February 23, 2023.
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 12**  **- 6405** 

TRAVIS MANDELL KEMP, a/k/a Travis Kemp , Plaintiff

– Appellant ,

v. OFFICER JOHNSON, GCDC; PHILLIP ANDERSON, Greenwood County Detention Center; SHARON MIDDLETON, Cpt GCDC; LUKE LARK, Lt GCDC; OFFICER BROOKS, GCDC , Defendants

- Appellees

.

Appeal from the United States District Court for the District of South Carolina , at Aiken

. Terry L. Wooten , District Judge. ( 1:09

- cv - 03195

- TLW )

Submitted : July 17, 2012 Decided: August 6, 2012

Before KING and GREGORY , Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by un published per curiam opinion

.
Travis Mandell Kemp, Appellant Pro Se. William Henry Davidson, II, Joel Steve Hughes, DAVIDSON & LINDEMANN, PA, Columbia, South Carolina; Kristy Grafton Goldberg, Columbia, South Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Travis Mandell Kemp appeals the district co urt ’ s order accepting the recommendation of the magistrate judge and denying
relief on his 42 U.S.C. § 1983 (200 6 ) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. Kemp v.
Johnson , No. 1:09

- cv - 03195

- TLW (D.S.C. Feb. 2, 2012) . We deny Kemp’s motion for appointment of counsel and dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
July 23, 2015

Mr. Brian Morson

12135 Sand Pebble Way

Orlando, FL 32824

Dear Mr. Mrson:

This letter is to inform you that we are unable to process your request for an exemption from 

Title 14, Code of Federal Regulations (14 CFR). It explains why we can not process your 

request and what you should do in the next 30 days.

Why We Can Not Process Your Request

We entered your May 21, 2015 exemption request into the public docket (No. FAA-2015-

1766), but we are unable to process your request any further. The information you sent does

not comply with the requirements of § 11.81 (copy enclosed). For us to consider the request 

any further, you must send us all of the following:

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole.

 Any additional information, views, or arguments available to support your request.

What You Should Do

If you want us to process your request any further, you must send the information described 

earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your 

petition for exemption at least 120 days before the proposed effective date of the exemption.
2

If We Do Not Hear From You

If we do not hear from you within 30 days, we will close the docket without notifying you 

further. If you have any questions or require additional time, you may call (202) 267-9677.

Sincerely,

/s/

Brittany Newton

Program Analyst, Airmen and 

 Airspace Rules Division

Enclosure
<TABLE> <S> <C>
                  
<ARTICLE>               5
<MULTIPLIER>            1000
                        
<S>                                             <C>
<PERIOD-TYPE>                                         3-MOS
<FISCAL-YEAR-END>                               DEC-31-1997
<PERIOD-END>                                    MAR-31-1997
<CASH>                                                30511
<SECURITIES>                                              0
<RECEIVABLES>                                         59026
<ALLOWANCES>                                              0
<INVENTORY>                                           49115
<CURRENT-ASSETS>                                     143223
<PP&E>                                                98527
<DEPRECIATION>                                        45079
<TOTAL-ASSETS>                                       218202
<CURRENT-LIABILITIES>                                 66071
<BONDS>                                               35125
<COMMON>                                               2013
<PREFERRED-MANDATORY>                                     0
<PREFERRED>                                               0
<OTHER-SE>                                           107697
<TOTAL-LIABILITY-AND-EQUITY>                         218202
<SALES>                                               92207
<TOTAL-REVENUES>                                      92207
<CGS>                                                 63292
<TOTAL-COSTS>                                         63292
<OTHER-EXPENSES>                                          0
<LOSS-PROVISION>                                          0
<INTEREST-EXPENSE>                                      325
<INCOME-PRETAX>                                       10079
<INCOME-TAX>                                           3557
<INCOME-CONTINUING>                                    6553
<DISCONTINUED>                                          281
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                           6834
<EPS-PRIMARY>                                           .42
<EPS-DILUTED>                                           .42
        

</TABLE>
[Federal Register Volume 65, Number 197 (Wednesday, October 11, 2000)]
[Notices]
[Page 60420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-26046]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal; Energy Regulatory Commission

[Docket No. RP00-426-001]


Texas Gas Transmission Corporation; Notice of Compliance Filing

October 4, 2000.
    Take notice that on September 29, 2000, Texas Gas Transmission 
Corporation (Texas Gas) tendered for filing as part of its FERC Gas 
Tariff, First Revised Volume No. 1, the following tariff sheets to 
become effective:

Substitute Sixth Revised Sheet No. 235
Substitute Fourth Revised Sheet No. 236

    In this compliance filing, Texas Gas hereby provides the 
clarifications and/or tariff modifications required by the August 31, 
2000 Order of the Commission.
    Texas Gas states that copies of the revised tariff sheets are being 
mailed to Texas Gas's jurisdictional customers, interested state 
commissions, and those persons appearing on the official service list.
    Any person desiring to protest said filing should file a protest 
with the Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426, in accordance with Section 285.211 of the 
Commission's Rules and Regulations. All such protests must be filed in 
accordance with Section 154.210 of the Commission's Regulations. 
Protests will be considered by the Commission in determining the 
appropriate action to be taken, but will not serve to make protestants 
parties to the proceedings. Copies of this filing are on file with the 
Commission and are available for public inspection in the Public 
Reference Room. This filing may be viewed on the web at http://www.ferc.fed.us/online/rims.htm (call 202-208-2222 for assistance).

Linwood A. Watson, Jr.,
Acting Secretary.
[FR Doc. 00-26046 Filed 10-10-00; 8:45 am]
BILLING CODE 6717-01-M
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                             185
<SECURITIES>                                         0
<RECEIVABLES>                                   20,473
<ALLOWANCES>                                     1,920
<INVENTORY>                                     31,903
<CURRENT-ASSETS>                                54,428
<PP&E>                                          13,914
<DEPRECIATION>                                   8,093
<TOTAL-ASSETS>                                  62,734
<CURRENT-LIABILITIES>                           32,649
<BONDS>                                         22,489
<COMMON>                                           160
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                       7,436
<TOTAL-LIABILITY-AND-EQUITY>                    62,734
<SALES>                                         24,927
<TOTAL-REVENUES>                                24,927
<CGS>                                           20,157
<TOTAL-COSTS>                                   20,157
<OTHER-EXPENSES>                                 4,694
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,179
<INCOME-PRETAX>                                (1,103)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (1,103)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,103)
<EPS-PRIMARY>                                    (.08)
<EPS-DILUTED>                                    (.08)
        

</TABLE>
#### SOWELLS v. STATE.

No. 27029.

Court of Criminal Appeals of Texas.

June 9, 1954.

No attorney on appeal.

Wesley Dice, State’s Atty., Austin, for the State.

MORRISON, Judge.

The offense is the unlawful possession of beer, whiskey and wine for the purpose of sale in a dry area; the punishment, a fine of $250.

The record contains no notice of appeal, and this Court is without jurisdiction.

The appeal is dismissed.
Exhibit 32.1 - President Certification (Section 906)

                        CERTIFICATION PURSUANT TO
                         18 U.S.C. SECTION 1350,
                         AS ADOPTED PURSUANT TO
             SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of MyQuoteZone, Inc. (the "Company")
on Form 10-KSB for the period ending September 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report").
I, Eduard Tabara, President of the Company, certify, pursuant to 18 U.S.C.
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of my knowledge and belief:

               (1)   The Report fully complies with the requirements of
                     section 13(a) or 15(d) of the Securities Exchange Act
                     of 1934; and

               (2)   The information contained in the Report fairly presents,
                     in all material respects, the financial condition and
                     result of operations of the Company.

/s/ Eduard Tabara
-----------------------
    Eduard Tabara
    President


Date  December 29, 2006
      -----------------


<PAGE>
**Exhibit      32.1**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

|   | (1) | the                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (2) | the                information contained in the Report fairly presents, in all material                respects, the financial condition and result of operations of the                Company. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                     |                                   |                               |
|------------------------------------------|----------------------------------------|------------------------------------|
|                                     |                                        |
|                                |                              |                          |
| Date:                  November 20, 2006 | By:                          | /s/ Wenxia                Guo |
|                                     | Wenxia                Guo              |
|                                     | Chief                Executive Officer |
Exhibit 32.1



Certification
of Principal Executive and Financial Officer

Pursuant
to 18 U.S.C. Section 1350, As Adopted Pursuant to

Section 906
of the Sarbanes-Oxley Act of 2002



In connection
with the Amendment to the Annual Report of United American Petroleum Corp., a Nevada corporation (the “Company”) on
Form 10-K for the year ending December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), Michael Carey, Chief Executive Officer, Chief Financial Officer, President, Treasurer and a director of
the Company, certifies to the best of his knowledge, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------





|/s/ Michael Carey                                                                                                                                                      |  |  |  | 
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  |  |  | 
|Michael Carey
        Chief Executive Officer and Chief Financial Officer,
        (Principal Executive Officer and Principal Financial Officer)
        July 21, 2015 |  |  |  |
### NOTE: This order is nonprecedential.



## United States Court of Appeals for the Federal Circuit 2009-1427 SANOFI-AVENTIS U.S. LLC, SANOFI-AVENTIS, and

DEBIOPHARM S.A.,

Plaintiffs-Appellants,

v. SANDOZ, INC.,

Defendant-Appellee, and TEVA PARENTERAL MEDICINES, INC., TEVA PHARMACEUTICALS USA, INC., and PHARMACHEMIE BV,

Defendants-Appellees, and MAYNE PHARMA LIMITED, MAYNE PHARMA (USA) INC., HOSPIRA AUSTRALIA

PTY LTD., and HOSPIRA, INC.,

Defendants-Appellees, and BARR LABORATORIES, INC. and PLIVA-LACHEMA A.S., Defendants-Appellees, and W.C. HERAEUS GMBH,

Defendant-Appellee, and APP PHARMACEUTICALS, INC. and ABRAXIS BIOSCIENCE, INC.,Defendants-Appellees, and ACTAVIS TOTOWA LLC, ACTAVIS, INC., and ACTAVIS GROUP HF, Defendants-Appellees, and FRESENIUS KABI ONCOLOGY PLC (formerly known as Dabur Oncology plc) and FRESENIUS KABI PHARMA LIMITED (formerly known as Dabur Pharma Limited), Defendants-Appellees, and SUN PHARMACEUTICAL INDUSTRIES LTD. and CARACO PHARMACEUTICAL LABORATORIES, LTD.,

Defendants-Appellees, and EBEWE PHARMA GES.M.B.H. NFG KG,

Defendants, and MUSTAFA NEVZAT ILAC SANAYII A.S. (also known as MN Pharmaceuticals), PAR PHARMACEUTICAL COMPANIES, INC., and PAR PHARMACEUTICAL, INC., Defendants-Appellees. On appeal from the United States District Court for the District of New Jersey in case

no. 3:07-cv-2762, Judge Joel A. Pisano.

ON MOTION Before MAYER, CLEVENGER, and RADER, Circuit Judges. MAYER, Circuit Judge. ORDER

2009-1427 - 2 -Mayne Pharma Limited et al. (Mayne) and Teva Parenteral et al. (Teva) move for

clarification of the court's July 10, 2009 order granting Sanofi-Aventis U.S. LLC et al.'s (Sanofi) motion for a stay, pending appeal, of the judgment of the United States District Court for the District of New Jersey entered on June 30, 2009 and also move for a conditional limited remand to the district court for the purpose of fixing the amount of a supersedeas bond. Sandoz, Inc. responds. Mayne and Teva move for a 14-day extension of time, until August 7, 2009, to file a petition for panel rehearing and/or rehearing en banc of the court's July 10 order. Ebewe Pharma Ges.m.b.H. Nfg.KG moves for leave to be removed from this appeal due to a consent judgment entered by the district court resolving the litigation between Ebewe and Sanofi. Upon consideration thereof, IT IS ORDERED THAT: The motion for clarification is denied. The motion for a limited remand is deemed moot. The motion for an extension of time to file a rehearing petition is granted. The motion to remove Ebewe from this appeal is granted to the extent that Ebewe is no longer designated as an appellee in the court's caption. The revised official caption is reflected above.

FOR THE COURT 

### JUL 24 2009 /s/ Jan Horbalv Date Jan Horbaly Clerk Pits, U.S. wow oF APPEALS PM THE FEDERAL CIRCUIT

2009-1427 - 3 - JUL 2 4 2009 JAN NONtimur CLERKcc: Dominick A. Conde, Esq.

Frederick H. Rein, Esq. Gail J. Standish, Esq. Patricia J. Thompson, Esq. Scott B. Feder, Esq. Steven Lieberman, Esq. Steven A. Maddox, Esq. Charles D. Ossola, Esq. Andrew M. Berdon, Esq. Daniel G. Brown, Esq. Steven H. Sklar, Esq. s19
1

IN THE UNITED STATES DISTRICT COURT 

FOR THE WESTERN DISTRICT OF TEXAS 

AUSTIN DIVISION

BRYNNE SOUKUP,

Plaintiff, 

Civil Action No. 1:20-cv-648-RP 

v. 

FRONTIER AIRLINES, INC. and 

FLIGHT SERVICES & SYSTEMS, LLC, 

Defendants. 

________________________________/

UNOPPOSED MOTION TO SUBSTITUTE COUNSEL 

AND NOTICE OF APPEARANCE

Plaintiff, BRYNNE SOUKUP, by and through her undersigned counsel, 

hereby files this motion to substitute counsel Brett C. Beeler for Trenton N. Lacy.

Mr. Lacy is no longer employed by the ROSS • SCALISE LAW GROUP and 

will no longer be able to represent Plaintiff in this matter. 

Going forward Mr. Beeler will be attorney-in-charge and counsel of record 

for the ROSS • SCALISE LAW GROUP and therefore makes this appearance.

CERTIFICATE OF CONFERENCE

I hereby certify that I have conferred with counsel for Defendant regarding 

the relief requested herein and have been authorized to represent that the Defendant 

are unopposed to the granting of this Motion.

Case 1:20-cv-00648-RP Document 40 Filed 08/03/21 Page 1 of 2
2

CERTIFICATE OF SERVICE

I hereby certify that on August 3, 2021, I electronically filed the foregoing 

with the Clerk of the Court using CM/ECF system, which will send notification to 

all counsel of record.

ROSS • SCALISE LAW GROUP

1104 San Antonio Street

Austin, Texas 78701

(512) 474-7677 Telephone

(512) 474-5306 Facsimile

/s/ Brett C. Beeler

BRETT C. BEELER

Texas Bar No. 24097357

Brett@rosslawgroup.com 

Daniel B. Ross 

State Bar No. 00789810

Dan@rosslawgroup.com

ATTORNEYS FOR PLAINTIFF

Case 1:20-cv-00648-RP Document 40 Filed 08/03/21 Page 2 of 2